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Osteoarthritis (OA), the most common articular disorder in hu-
mans, is a complex multifactorial disease with a major genetic
etiological component. However, despite a complex etiology and
a variety of predisposing risk factors, the pathological processes
within the articular cartilage and the subchondral bone are re-
markably uniform. Therefore, one can define a common pathway
of OA-characteristic pathogenetic steps, upstream of the de-
struction of articular cartilage and joint dysfunction. At an early
stage, increased proteoglycan synthesis and degradation is as-
sociated with swelling of the cartilage, increased chondrocyte
proliferation and cell clustering; this is followed by net loss of
proteoglycans, decreased chondrocyte numbers and release of
matrix-degrading enzymes. These enzymes degrade the collage-
nous matrix, resulting in disruption and fragmentation of collagen
fibers. Although the process leads to cartilage destruction, the
underlying cellular mechanism involves activation of chondro-
cytes from a maintenance state to a repair mode.
The molecular nature of this activated repair mode is determined
by the properties of differentiated chondrocytes, explaining why
the pathogenetic processes in osteoarthritis appear to be rela-
tively independent of the nature of the disease-causing event(s).
For this reason, detailed molecular studies of the pathogenesis of
even rare forms of osteoarthritis are likely to provide insights into
the processes underlying the more common forms of the disease.
These concepts are the basis for studies of hereditary forms of
OA caused by mutations in genes encoding matrix molecules
in cartilage. Such hereditary forms range from severe disease
in early life, to mild disorders that become evident only late
... (Reginato and Olsen, 2002). The disorders can be divided
into three major groups: (a) Early-onset OA associated with an
underlying familial chondrodysplasia; (b) OA associated with ab-
normal deposition of mineral crystals in cartilage; (c) primary
generalized OA with wild chondrodysplasia. In the first group
are disorders caused by mutations in genes encoding cartilage
collagens II, IX, and XI. A large number of mutations associated
with early-onset OA have been identified in these collagens and
mouse models for studies of pathogenetic mechanisms under-
lying disease progression are available (Jakkula et al., 2005;
Reginato and Olsen, 2002). Studies in our laboratory resulted
in identification of the first mutations in collagen IX and XI in
humans and established relevant mouse models (Fassler et al.,
1994; Li et al., 1995; Muragaki et al., 1996; Vikkula et al., 1995).
During the past 5 years, detailed molecular studies of the OA
disease process in knee joints of collagen IX and XI mutant
mice have been conducted (Hu et al., in press; Xu et al., 2003;
Xu et al., 2005). The results indicate that disease progression
in both mutants is associated with a time-dependent series of
specific molecular changes that eventually results in loss of ar-
ticular cartilage. Importantly, similar changes are seen even in
wild-type mice in which OA is initiated by surgical mobilization of
the medial meniscus and in samples of articular cartilage from
OA patients undergoing joint replacement surgery!
At an early stage of disease progression, enhanced turnover of
cartilage proteoglycans is associated with increased chondro-
cyte proliferation. At a second stage, chondrocytes upregulate,
in an autocrine manner, expression of the collagen-binding ty-
rosine kinase receptor DDR2. Experiments with cultured human
and mouse chondrocytes indicate that DDR2 upregulation re-
quires contact of chondrocytes with triple-helical collagen II. At
a third stage, signaling from DDR2 in turn results in upregu-
lated expression of the collagen II-degrading enzyme MMP13
and degradation of the collagen scaffold within the cartilage.
Signaling from DDR2 to MMP13 requires phosphorylation of the
cytoplasmic tail of DDR2 and is mediated by pathways that differ
from the autocrine pathway by which DDR2 activation by triple-
helical collagen upregulates expression of DDR2. The autocrine
regulation of DDR2 expression represents a positive feed-back
loop that serves to accelerate cartilage destruction once the
disease process reaches the second stage. Since upregulated
expression of DDR2 in articular cartilage occurs in hereditary OA
as well as in the common primary form, DDR2 is emerging as
an exciting target for therapeutic intervention to slow down the
disease progression in OA.
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